Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 143

1.

Cannabinoids in glaucoma: a primary screening procedure.

Elsohly MA, Harland E, Murphy JC, Wirth P, Waller CW.

J Clin Pharmacol. 1981 Aug-Sep;21(8-9 Suppl):472S-478S.

PMID:
6271842
[PubMed - indexed for MEDLINE]
2.

Cannabinoids in glaucoma II: the effect of different cannabinoids on intraocular pressure of the rabbit.

ElSohly MA, Harland EC, Benigni DA, Waller CW.

Curr Eye Res. 1984 Jun;3(6):841-50.

PMID:
6329602
[PubMed - indexed for MEDLINE]
3.

Intraocular pressure following systemic administration of cannabinoids.

Green K, Symonds CM, Oliver NW, Elijah RD.

Curr Eye Res. 1982-1983;2(4):247-53.

PMID:
6295702
[PubMed - indexed for MEDLINE]
4.

The quasi-morphine withdrawal syndrome: effect of cannabinol, cannabidiol and tetrahydrocannabinol.

Chesher GB, Jackson DM.

Pharmacol Biochem Behav. 1985 Jul;23(1):13-5.

PMID:
2994117
[PubMed - indexed for MEDLINE]
5.

Central nervous system and peripheral mechanisms in ocular hypotensive effect of cannabinoids.

Liu JH, Dacus AC.

Arch Ophthalmol. 1987 Feb;105(2):245-8.

PMID:
3813958
[PubMed - indexed for MEDLINE]
6.

Action of cannabidiol on the anxiety and other effects produced by delta 9-THC in normal subjects.

Zuardi AW, Shirakawa I, Finkelfarb E, Karniol IG.

Psychopharmacology (Berl). 1982;76(3):245-50.

PMID:
6285406
[PubMed - indexed for MEDLINE]
7.
8.

Psychoactive cannabinoids reduce gastrointestinal propulsion and motility in rodents.

Shook JE, Burks TF.

J Pharmacol Exp Ther. 1989 May;249(2):444-9.

PMID:
2542532
[PubMed - indexed for MEDLINE]
9.

Effect of sublingual application of cannabinoids on intraocular pressure: a pilot study.

Tomida I, Azuara-Blanco A, House H, Flint M, Pertwee RG, Robson PJ.

J Glaucoma. 2006 Oct;15(5):349-53.

PMID:
16988594
[PubMed - indexed for MEDLINE]
10.

Neuroprotective and intraocular pressure-lowering effects of (-)Delta9-tetrahydrocannabinol in a rat model of glaucoma.

Crandall J, Matragoon S, Khalifa YM, Borlongan C, Tsai NT, Caldwell RB, Liou GI.

Ophthalmic Res. 2007;39(2):69-75. Epub 2007 Feb 2.

PMID:
17284931
[PubMed - indexed for MEDLINE]
11.

Pharmacology of the intraocular pressure (IOP) lowering effect of systemic dexanabinol (HU-211), a non-psychotropic cannabinoid.

Beilin M, Neumann R, Belkin M, Green K, Bar-Ilan A.

J Ocul Pharmacol Ther. 2000 Jun;16(3):217-30.

PMID:
10872919
[PubMed - indexed for MEDLINE]
12.
13.

Soft cannabinoid analogues as potential anti-glaucoma agents.

Buchwald A, Derendorf H, Ji F, Nagaraja NY, Wu WM, Bodor N.

Pharmazie. 2002 Feb;57(2):108-14.

PMID:
11878185
[PubMed - indexed for MEDLINE]
14.

Psychoactive cannabinoids increase mortality and alter acute phase cytokine responses in mice sublethally infected with Legionella pneumophila.

Smith MS, Yamamoto Y, Newton C, Friedman H, Klein T.

Proc Soc Exp Biol Med. 1997 Jan;214(1):69-75.

PMID:
9012363
[PubMed - indexed for MEDLINE]
15.

Soft cannabinoid analogues as potential anti-glaucoma agents.

Buchwald A, Browne CE, Wu WM, Ji F, Bodor N.

Pharmazie. 2000 Mar;55(3):196-201.

PMID:
10756540
[PubMed - indexed for MEDLINE]
16.

Interaction of cannabis and general anaesthetic agents in mice.

Chesher GB, Jackson DM, Starmer GA.

Br J Pharmacol. 1974 Apr;50(4):593-9.

PMID:
4280927
[PubMed - indexed for MEDLINE]
Free PMC Article
17.
18.

Ocular hypotension, ocular toxicity, and neurotoxicity in response to marihuana extract and cannabidiol.

Colasanti BK, Brown RE, Craig CR.

Gen Pharmacol. 1984;15(6):479-84.

PMID:
6098513
[PubMed - indexed for MEDLINE]
19.

Topical delta 9-tetrahydrocannabinol and aqueous dynamics in glaucoma.

Merritt JC, Perry DD, Russell DN, Jones BF.

J Clin Pharmacol. 1981 Aug-Sep;21(8-9 Suppl):467S-471S.

PMID:
6271841
[PubMed - indexed for MEDLINE]
20.

Physiologic observations in a controlled clinical trial of the antiemetic effectiveness of 5, 10, and 15 mg of delta 9-tetrahydrocannabinol in cancer chemotherapy. Ophthalmologic implications.

Levitt M, Wilson A, Bowman D, Kemel S, Krepart G, Marks V, Schipper H, Thomson G, Weinerman B, Weinerman R.

J Clin Pharmacol. 1981 Aug-Sep;21(8-9 Suppl):103S-109S.

PMID:
6271814
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk